WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Stock Ownership - Who owns 10x Genomics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have 10x Genomics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Serge SaxonovChief Executive Officer2026-04-145,000$24.56
$122.79kSell
Serge SaxonovChief Executive Officer2026-03-245,000$19.52
$97.61kSell
Serge SaxonovChief Executive Officer2026-03-2310,000$19.13
$191.30kSell
Serge SaxonovChief Executive Officer2026-03-0214,292$22.67
$323.99kSell
Serge SaxonovChief Executive Officer2026-03-021,860$23.18
$43.11kSell
Sarah A. TeichmannDirector2026-02-257,579$19.41
$147.11kSell
Benjamin J. HindsonTitle President and Chief Scientific Officer Exhibit 24.1 - Power of Attorney2026-02-237,826$18.58
$145.38kSell
Serge SaxonovChief Executive Officer2026-02-239,632$18.58
$178.92kSell
Adam TaichChief Financial Officer2026-02-238,968$18.58
$166.59kSell
Serge SaxonovChief Executive Officer2026-01-0550,000$1.20
$60.00kBuy

1 of 2

TXG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TXG insiders and whales buy or sell their stock.

TXG Shareholders

What type of owners hold 10x Genomics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.97%17,740,972$437.85MInstitution
Ark Investment Management LLC9.23%11,717,317$289.18MInstitution
Blackrock Inc7.94%10,079,913$248.77MInstitution
Vanguard Portfolio Management LLC5.45%6,912,936$170.61MInstitution
Paladin Capital Management LLC4.42%5,617,583$138.64MInsider
Quantinno Capital Management LP4.26%5,411,761$133.56MInstitution
Vanguard Capital Management LLC4.15%5,269,586$130.05MInstitution
Sumitomo Mitsui Trust Group Inc4.03%5,110,214$126.12MInstitution
Amova Asset Management Americas Inc4.02%5,104,178$125.97MInstitution
Bryan E. Roberts3.42%4,336,630$107.03MInsider

1 of 3

TXG vs Health Information Service Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TXG86.47%13.53%Net SellingNet Selling
MMED11.35%88.65%Net SellingNet Selling
PRVA45.30%54.70%Net SellingNet Selling
DOCS66.13%11.70%Net SellingNet Selling
WAY61.49%38.51%Net SellingNet Buying
View Top Health Information Service Stocks

10x Genomics Stock Ownership FAQ

Who owns 10x Genomics?

10x Genomics (NASDAQ: TXG) is owned by 98.60% institutional shareholders, 15.42% 10x Genomics insiders, and 0.00% retail investors. Paladin Capital Management LLC is the largest individual 10x Genomics shareholder, owning 5.62M shares representing 4.42% of the company. Paladin Capital Management LLC's 10x Genomics shares are currently valued at $138.64M.

If you're new to stock investing, here's how to buy 10x Genomics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.